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Abstract We have detected sialyltransferase activity of recom- 
binant mouse STX, which was cloned from rat brain as a new 
member of the sialyltransferase family, but sialyltransferase ac- 
tivity of which had not been detected previously [Livingston and 
Paulson, J. Biol. Chem. (1993) 268, 11504-11507]. The activity 
of mouse STX was specific toward sialylated glycoproteins. N- 
Glycanase treatment and linkage-specific sialidase treatment of 
glycoproteins revealed that STX transfers sialic acids through 
a2,8-1inkages to only N-linked oligosaccharides of glycoproteins. 
However, polymerase activity for polysialic acid synthesis was 
not detected for this sialyltransferase. Since this ~2,8-sialyltrans- 
ferase gene is highly restricted in fetal and newborn brain, it may 
be involved in the polysialylation of glycoproteins, especially of 
N-CAM. 
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1. Introduction 
Sialic acids are key determinants of carbohydrate structures 
involved in a variety of biological processes, such as cell~cell 
interaction and cell differentiation [1-3]. The enzymes catalyz- 
ing sialic acid transfer to acceptor carbohydrate chains, namely 
sialyltransferases, have been suggested to number at least 
10 12, since sialylated oligosacchride structures vary consider- 
ably in both the linkage of the sialic acid and the acceptor 
oligosaccharides to which sialic acids are attached. 
In recent years, several sialyltransferase genes have been 
cloned [4-11]. Comparison of the cloned sialyltransferases has 
revealed two highly conserved regions in their active domains, 
named sialyl motifs L and S [11, 12]. Based on sialyl motif  L, 
Livingston and Paulson cloned the cDNA of a new member of 
the sialyltransferase family from rat, which was named STX, 
by a PCR-based approach [12]. The rat STX gene coded for a 
protein that contains the complete sialyl motifs and is predicted 
to have a type II membrane topology characteristic of glyco- 
syltransferases, like the other sialyltransferase genes so far 
cloned. However, they did not detect activity of the enzyme. 
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This gene was reported only to be expressed in newborn brain, 
but not in other tissues including adult brain, suggesting that 
the expression of rat STX is highly regulated during brain 
development. 
We cloned the mouse STX gene from 3-day-old mouse brain 
cDNA, and the activity of the mouse STX was examined using 
the protein A-fused enzyme. In this paper, we describe the 
sialyltransferase activity of mouse STX. STX is most probably 
an ~2,8-sialyltransferase which is specific for sialylated N- 
linked oligosaccharides. 
2. Materials and methods 
2.1. Materials 
Unless otherwise indicated, the materials used in this study were 
essentially the same as previous papers [8-11]. Lactosylceramide, GM3, 
GD3, GDla, GDlb, and GTlb were purchased from Sigma; GQlb and 
paragloboside were from IATRON. a2,3- and ~2,6-sialylparaglo- 
bosides were kind gifts from Dr. Iwamori, Tokyo University. Fetuin, 
asialofetuin, al-acid glycoprotein, ovomucoid, and bovine submaxil- 
lary mucin were from Sigma. Asialo-~l-acid glycoprotein and asialo- 
ovomucoid were prepared by mild acid hydrolysis of glycoproteins 
(0.02 N HCI, 80°C, 1 h). 
2.2. PCR cloning of the mouse STX 
PCR was performed using primers (5'-primer, TGAAGAATAAG- 
CATTTCCAGACTTGTGCCATCGTGGGCAA; 3'-primer, CAAT- 
GGGAAGGGCCAGAAGCCATA) derived from the rat STX se- 
quence [12]. Total RNA from mouse fetal brain was used as a template 
to synthesize cDNA. Amplification was carried out with 35 cycles of 
94°C for 40 s, 55°C for 40 s, and 72°C for 1 min. The 0.5-kb PCR 
products were blunt-ended, kinated, and then subcloned into the SmaI 
site of pUC 119. Subclones were characterized bysequencing. Random- 
primed 3-day-old mouse brain cDNA was ligated with EcoRI-digested 
2ZAPII (Stratagene). The resultant library was packaged using a Strat- 
agene GigapackII packaging extract and plated on Escherichia coli 
XL- 1 Blue (Stratagene). Approximately 106 plaques were screened with 
the 0.5-kb PCR fragment, and the cDNA encoding mouse STX was 
cloned by the standard molecular cloning techniques described by Ma- 
niatis et al. [13]. 
2.3. Construction and purification of STX fused with protein A 
A truncated form of STX, lacking the first 33 amino acids of the open 
reading frame, was prepared by PCR amplification with a 5'-primer 
containing an in-frame XhoI site (5'-AGAAGAATCTCGAGTTCT- 
GGAGGCAGAGGTACAATC-3') and a Y-primer containing an 
XhoI site (5'-GAGCCACTCGAGTCCCATGGGCTGTCCTCCTT- 
A-3'). The fusion vector, pcDSA, was constructed by inserting aprotein 
A IgG binding domain, which was prepared by PCR amplification from 
the pAMoA vector [7], into the EcoRI site of the pcDS vector [8]. The 
amplified DNA fragment was subcloned into the l(hoI site of pcDSA 
to yield pcDSA-STX, resulting in fusion of STX to the IgM signal 
sequence and protein A. COS-7 cells were transfected with pcDSA-STX 
(10 ,ug) by the DEAE-dextran method and cultured for 16 h in Dul- 
becco's modified Eagle medium supplemented with 2% fetal bovine 
serum. The medium was then replaced with serum-free medium (Mac- 
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rophage-SFM, Gibco BRL) and the cells were cultured for another 32 
h. After 48 h transfection, the culture medium was collected and the 
protein A-mouse STX expressed in the medium was adsorbed to IgG- 
Sepharose (15 ¢tl of resin per 10 ml of culture medium) at 4°C for 16 
h. The resin was collected by centrifugation, washed three times with 
phosphate-buffered saline, suspended in 50/A (final volume) of Dul- 
becco's modified Eagle medium without fetal bovine serum, and used 
as the soluble enzyme. 
2.4. Northern blot analysis 
5 pg of total RNA was fractionated on a denaturing formaldehyde- 
agarose gel (1%) and then transferred to a nylon membrane (Nytran, 
Schleicher & Schuell). A l157-bp PCR fragment, he full-length STX 
amplified using synthetic oligonucleotide primers (5'-GCACTCGAG- 
CCCACCATGCAGCTGCAGTT-3' and 5'-GAGCCACTCGAGTC- 
CCATGGGCTGTCCTCCTTA-3'), was radiolabeled and used as a 
probe. 
2.5. Sialyltransferase assays and product characterization 
The enzyme activity was measured in the presence of 0.1 M sodium 
cacodylate buffer (pH 6.0), 10 mM MgC12, 2 mM CaC12, 0.5% Triton 
CF-54, 34 pM CMP-[~4C]NeuAc (0.4pCi), 1 mg/ml acceptor substrate, 
and 2/11 enzyme preparation i  a total volume of 10 pl, as described 
in the previous papers [10,11]. After 6 h incubation at 37°C, the reaction 
was terminated by the addition of SDS-PAGE loading buffer (10 pl), 
and the incubation mixtures were directly subjected to SDS-PAGE (for 
glycoprotein acceptors). For glycolipid acceptors, the incubation mix- 
tures were applied on a C-18 column, wich was washed with water. The 
glycolipids were eluted from the column with methanol, dried, and then 
subjected to chromatography on an HPTLC plate with a solvent system 
of chloroform/methanol/0.02% CaCIz (55:45:10), as described previ- 
ously [10]. Acceptor substrates were visualized by staining with 
Coomassie brilliant blue (for glycoproteins) or by the orcinol/H2SO4 
method (for glycolipids). The radioactive materials in glycoproteins or
glycolipids were visualized with a BAS2000 radio image analyzer (Fuji 
Film) and the radioactivity incorporated into acceptor glycoproteins 
was counted. 
For linkage analysis of sialic acids, czl-acid glycoprotein sialylated 
with the enzyme was precipitated with 70% ethanol, washed three times 
with 70% ethanol, dissolved in water, and then digested with linkage- 
specific recombinant sialidase, NANAase I (specific for c~2,3-1inked 
sialic acids), NANAase II (specific for cz2,3- and ~2,6-1inked sialic 
acids), orNANAase III (specific for c~2,3-, c~2,6-, and ~2,8-1inked sialic 
acids) (FACE, Glyko Inc.) at 37°C for 2 h. 
For preparation of de-sialylated orde-N-glycosylated glycoproteins, 
glycoproteins (100 ¢tg) were digested with NANAase I, NANAase II, 
or NANAase III in a total volume of 20/zl for 2 h at 37°C, or with 
N-glycanase (1.5 U; Genzyme) in a total volume of 20 ,ul at 37°C for 
20 h. After inactivation of the enzyme by boiling for 3 min, the resulting 
de-sialylated or de-N-glycosylated glycoproteins were used as accep- 
tors. 
3. Resu l t s  
The cDNA of mouse STX (mSTX) was cloned by a PCR- 
based approach to obtain a cDNA fragment encoding the con- 
served sialyl motifs, followed by screening of a cDNA library 
from mouse brain. Comparison with the rat STX sequence 
showed that there was 97.2% identity at the nucleotide sequence 
level in the predicted coding region and 99.2% conservation at 
the amino acid sequence l vel. The mRNA size and distribution 
of the mSTX gene were determined by Northern blot analysis 
(Fig. 1). Among the various tissues examined, a major mRNA 
of approximately 5.0 kb was detected in fetal and newborn 
brain, similar to that seen in rat newborn brain [ 12] and human 
fetal brain [ 14]. Weak expression of the same size transcript was 
observed in testis and lung. 
Livingston and Paulson did not detect he activity of rat STX 
using several glycolipids, oligosaccharides, and asialoglycopro- 
teins [12]. We also could not detect the activity of soluble 
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Fig. 1. Northern blot analysis of the mouse STX gene. Total RNAs (5 
,ug) were prepared from 14 and 20 p.c. mouse mbryos (E-14 and E-20), 
3-day-postnatal (newborn), and 7-week-old (adult) mouse brains, and 
adult mouse tissues. The hybridization probe was the 1.2-kb XhoI 
fragment of a cDNA insert of pCD-STX. 28S and 18S indicated the 
positions of mouse ribosomal RNAs. 
protein A-fused mSTX as well as full-length mSTX using the 
following glycolipid acceptors: lactosylceramide, paraglo- 
boside, GM3, GD3, GDla ,  GDlb ,  GT lb ,  GQlb ,  c~2,3-sia- 
lylparagloboside, and ct2,6-sialylparagloboside. When cd-acid 
glycoprotein was used as an acceptor, we detected activity of 
soluble mSTX as well as full length mSTX (Fig. 2A). No activ- 
ity toward ~l-acid glycoprotein was observed in the culture 
medium or cell lysate obtained from cells transfected with the 
vector alone. Thus, mSTX exhibits ialyltransferase activity. As 
shown in Fig. 2B, sialylated glycoproteins uch as ~l-acid 
glycoprotein, fetuin, and ovomucoid served as acceptors for 
mSTX. However, human transferrin, one of sialylated 
glycoproteins, did not serve as an acceptor (data not shown). 
On the other hand, mSTX did not exhibit activity toward 
asialo-glycoproteins at all. The broad radioactive bands be- 
tween mucin and fetuin are derived from the enzyme prepara- 
tion because they were also observed for the reaction mixture 
without any substrate glycoproteins (Fig. 2B, lane 8). The link- 
ages of the incorporated sialic acids were analyzed by digestion 
of [~4C]sialylated czl-acid glycoprotein using linkage-specific 
sialidases. The incorporated [14C]sialic acids were completely 
resistant to treatment with c~2,3-specific or c~2,6- and cz2,3- 
specific sialidase, but almost completely disappeared on treat- 
ment with c~2,3-, ~2,6-, and c~2,8-specific sialidase, strongly sug- 
gesting that the sialic acids incorporated by mSTX were linked 
to terminal sialic acids through ~2,8-1inkages (Fig. 3A). The 
activity of STX toward de-sialylated glycoproteins on treat- 
ment with c¢2,3-specific sialidase was greatly reduced as com- 
pared with that toward non-treated glycoproteins, but was not 
completely abolished, whereas when glycoproteins were treated 
with ~2,3-and 0¢2,6-specific or c~2,3-, c~2,6-, and cx2,8-specific 
sialidase, the activity was completely abolished (Fig. 3B). 
Therefore STX may exhibit c~2,8-sialyltransferase ctivity to- 
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Fig. 2. Incorporation of sialic acids into various glycoproteins by mouse STX. (A) ~l-acid glycoprotein was incubated with the culture medium of 
COS-7 cells transfected with pcDSA-STX or pcDSA (Mock), as described in section 2, and then the reaction mixtures were analyzed by SDS-PAGE. 
In addition, full-length mouse STX was expressed in COS-7 cells (pcD-STX) and sialyltransferase activity was measured with ~l-acid glycoprotein 
using cell lysate as the enzyme. It should be noted that both culture medium (protein A-fused soluble STX) and cell lysate (full-length STX) of cells 
transfected with only STX gene showed clear sialic acid incorporation i to cd-acid glycoprotein. (B) Various glycoproteins were incubated with the 
protein A-fused mouse STX enzyme preparation. Lane 1, c~ 1-acid glycoprotein; lane 2, asialo-ct 1-acid glycoprotein; lane 3, fetuin; lane 4, asialofetuin; 
lane 5, ovomucoid; lane 6, asialo-ovomucoid; lane 7, bovine submaxillary mucin; lane 8, no acceptor substrate glycoprotein. It should be noted that 
aisalo-glycoproteins didnot serve as acceptors at all. 
ward both ~2,3- and c~2,6-1inked sialic acids. As shown in Fig. 
2B, bovine mucin, which contains only O-linked oligosac- 
charides, did not serve as an acceptor for mSTX. To determine 
whether the sialic acids are incorporated into N-l inked oligo- 
saccharides or O-linked oligosaccharides of glycoproteins, 
[14C]sialylated glycoproteins were digested with N-glycanase. 
The sialic acids incorporated into fetuin, which contains both 
N-l inked and O-linked oligosaccharides a well as those incor- 
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Fig. 3. Effect of linkage-specific sialidase treatment ofsubstrate glycoproteins on incorporated sialic acids and on activity of STX. (A) Linkage analysis 
of incorporated sialic acids: ~l-acid glycoprotein was sialylated with mouse STX and the sialylated glycoprotein was digested with ~z2,3-specific 
sialidase (NANAase I), ~z2,3- and ct2,6-specific sialidase (NANAase II), or ct2,3-, ~2,6-, and ct2,8-specific sialidase (NANAase III). The resulting 
glycoproteins were subjected to SDS-PAGE and radioactivity at the position of ~zl-acid glycoprotein was counted. The SDS-PAGE pattern is shown 
in the inset. (B) Effect of sialidase treatment of glyeporteins for STX activity: fetuin or ctl-acid glycoprotein (~zl-AGP) was digested with NANAase 
I, II and III, respectively, and the resulting de-sialylated glycoproteins were incubated with protein A-fused soluble mouse STX, and subjected to 
SDS-PAGE, and then the radioactivity incorporated into de-sialylated glycoprotein was visualized and quantified with a BAS2000 radio image 
analyzer. (C) I, II and III indicate treatment with no enzyme, NANAase I, NANAase II, and NANAase III, respectively. 
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Fig. 4. Effect of N-glycanase treatment of substrate glycoproteins for 
incorporated sialic acids and on activity of STX. (A) Glycoproteins 
were sialylated with mouse STX and then digested with N-glycanase 
(1.5 U) at 37°C for 36 h. (B) Glycoproteins were first digested with 
N-glycanase. Then the resulting de-N-glycosylated glycoproteins were 
incubated with mouse STX and CMP-[~4C]NeuAc, and the incorpo- 
rated sialic acids were visualized and counted. It should be noted that 
[~4C]sialic acids incorporated into fetuin was sensitive by N-glycanase 
treatment and that de-N-glycosylated fetuin did not serve as an accep- 
tor for mouse STX. 
porated into ~ 1-acid glycoprotein which contains only N-linked 
oligosaccharides, were completely released from the proteins 
(Fig. 4A). In addition, N-glycanase-treated f tuin did not serve 
as an acceptor (Fig. 4B). Therefore, mSTX exhibited activity 
only toward N-linked oligosaccharides. 
4. Discussion 
The following results strongly indicate that mouse STX is a 
novel a2,8-sialyltransferase sp cific for sialylated N-linked oli- 
gosaccharides of glycoproteins: (i) STX only exhibited activity 
toward sialylated glycoproteins, but not toward asialo- 
glycoproteins or all glycolipids tested including gangliosides; 
(ii) sialic acids incorporated into glycoproteins are sensitive to 
N-glycanase treatment; (iii) sialic acids incorporated into 
glycoproteins are resistant to treatment with ~2,3-specific and 
~2,3- and c~2,6-specific sialidases, but are completely released 
on ~2,3-, a2,6-, and ~2,8-specific sialidase treatment. Since 
sialylparagloboside (Neuacc~2,3/6Galfl 1,4GlcNAcfl 1,3-Galfl 1,- 
4Glcfll,1Cer) did not serve as an acceptor for mouse STX, STX 
should require not only the Neu~2,3/6Galfll,4GlcNAc 
sequence but more complex structure containing the Neuc~2,3/ 
6Galfl l,4GlcNAc sequence, such as complex-type oligo- 
saccharides of N-glycans, for a2,8-sialyltransfer. However, at 
this time, it is not clear which type of complex N-linked oligo- 
saccharide is a suitable acceptor for STX. Relevant studies are 
now in progress. 
The expression of the mouse STX gene as well as the rat and 
human STX genes is clearly regulated according to the tissue 
type and developmental stage [12,14]. The mouse STX gene is 
expressed only in fetal and newborn brain, but not in adult 
brain, suggesting that STX expression is closely related to brain 
development. I  is well known that N-CAM acquires a unique 
polysialic acid substituent on its N-linked oligosaccharides, in 
the fetal and newborn stages, and polysialic acid chains disap- 
pear from N-CAM in adult brain [15,16]. c~2,8-1inked sialic acid 
residues in mammalian glycoproteins have only been found in 
the polysialic acid chains of several glycoproteins, including 
N-CAM. Based on these facts and the expression pattern of the 
gene, STX is probably involved in the biosynthesis of the poly- 
sialic acid chains of N-CAM. However, STX itself does not 
exhibit sialic acid-polymerase activity, because colomic acid did 
not serve as an acceptor for mouse STX. Thus, STX may act 
as an initiator for the biosynthesis of polysialic acid chains in 
fetal and newborn N-CAM. 
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